| Association between menopausal transition stages and developing urinary incontinence LE Waetjen, J Ye, WY Feng, WO Johnson, GA Greendale, CM Sampselle, ... Obstetrics & Gynecology 114 (5), 989-998, 2009 | 133 | 2009 |
| An integrated genomic approach to identify predictive biomarkers of response to the Aurora kinase inhibitor PF-03814735 KE Hook, SJ Garza, ME Lira, KA Ching, NV Lee, J Cao, J Yuan, J Ye, ... Molecular Cancer Therapeutics, 2012 | 119 | 2012 |
| Factors associated with worsening and improving urinary incontinence across the menopausal transition LE Waetjen, WY Feng, J Ye, WO Johnson, GA Greendale, CM Sampselle, ... Obstetrics & Gynecology 111 (3), 667-677, 2008 | 79 | 2008 |
| Characterization of human corneal epithelial cell model as a surrogate for corneal permeability assessment: metabolism and transport CD Xiang, M Batugo, DC Gale, T Zhang, J Ye, C Li, S Zhou, EY Wu, ... Drug Metabolism and Disposition 37 (5), 992-998, 2009 | 71 | 2009 |
| FDA approval summary: brentuximab vedotin in first‐line treatment of peripheral T‐cell lymphoma NC Richardson, YL Kasamon, H Chen, RA de Claro, J Ye, ... The Oncologist 24 (5), e180-e187, 2019 | 70 | 2019 |
| Statistical method on nonrandom clustering with application to somatic mutations in cancer J Ye, A Pavlicek, EA Lunney, PA Rejto, CH Teng BMC bioinformatics 11, 1-9, 2010 | 61 | 2010 |
| FDA Approval Summary: Mogamulizumab-kpkc for Mycosis Fungoides and Sézary Syndrome PR Kasamon YL, Chen H, de Claro RA, Nie L, Ye J, Blumenthal GM, Farrell AT Clin Cancer Res, 2019 | 59 | 2019 |
| Meta-analysis of the technical performance of an imaging procedure: guidelines and statistical methodology EP Huang, XF Wang, KR Choudhury, LM McShane, M Gönen, J Ye, ... Statistical methods in medical research 24 (1), 141-174, 2015 | 55 | 2015 |
| A novel SND1-BRAF fusion confers resistance to c-Met inhibitor PF-04217903 in GTL16 cells though MAPK activation NV Lee, ME Lira, A Pavlicek, J Ye, D Buckman, S Bagrodia, SP Srinivasa, ... PloS one 7 (6), e39653, 2012 | 54 | 2012 |
| Practical considerations and recommendations for master protocol framework: basket, umbrella and platform trials C Lu, X Li, K Broglio, P Bycott, Q Jiang, X Li, A McGlothlin, H Tian, J Ye Therapeutic Innovation & Regulatory Science 55 (6), 1145-1154, 2021 | 43 | 2021 |
| Molecular predictors of sensitivity to the insulin-like growth factor 1 receptor inhibitor Figitumumab (CP-751,871) A Pavlicek, ME Lira, NV Lee, KA Ching, J Ye, J Cao, SJ Garza, KE Hook, ... Molecular cancer therapeutics 12 (12), 2929-2939, 2013 | 43 | 2013 |
| A Bayesian approach in design and analysis of pediatric cancer clinical trials J Ye, G Reaman, RA De Claro, R Sridhara Pharmaceutical Statistics, https://doi.org/10.1002/pst.2039, 2020 | 25 | 2020 |
| A review of the experience with pediatric written requests issued for oncology drug products AY Akalu, X Meng, GH Reaman, L Ma, W Yuan, J Ye Pediatric Blood & Cancer 68 (2), e28828, 2021 | 23 | 2021 |
| On the analysis of glycomics mass spectrometry data via the regularized area under the ROC curve J Ye, H Liu, C Kirmiz, CB Lebrilla, DM Rocke BMC bioinformatics 8, 1-12, 2007 | 14 | 2007 |
| An Optimal Two-Period Multiarm Platform Design with New Experimental Arms Added During the Trial JY Haitao Pan, Xiaomeng Yuan New England Journal of Statistics in Data Science, 2022 | 6* | 2022 |
| Practical considerations and recommendations for master protocol framework: basket, umbrella and platform trials. Ther Innov Regul Sci. 2021; 55 (6): 1145–54 CC Lu, XN Li, K Broglio, P Bycott, Q Jiang, X Li, A McGlothlin, H Tian, J Ye Epub 2021/06/24. doi: 10.1007/s43441-021-00315-7. PubMed PMID: 34160785, 0 | 5 | |
| An Overview of Current Statistical Methods for Implementing Quality Tolerance Limits R Kilaru, S Amodio, Y Li, C Wells, S Love, Y Zeng, J Ye, M Jelizarow, ... Therapeutic Innovation & Regulatory Science, DOI: 10.1007/s43441-023-00598-y, 2024 | 4 | 2024 |
| Considerations for master protocols using external controls J Chen, X Li, C Lu, S Yuan, G Yung, J Ye, H Tian, J Lin Journal of Biopharmaceutical Statistics, 1-23, 2024 | 4 | 2024 |
| Recent use of pediatric extrapolation in pediatric drug development in US J Ye, V Zhang, F Strimenopoulou, Y Zhao, H Pan, M Shabbout, M Gamalo Journal of Biopharmaceutical Statistics 33 (6), 681-695, 2023 | 4 | 2023 |
| Analysis and reporting of pediatric growth and development assessment from clinical trials: overview and challenges YJ Choi, N Barbier, S Fürst-Recktenwald, J Ye, DB Wajsbrot, E Ishida, ... Journal of Biopharmaceutical Statistics 33 (6), 786-799, 2023 | 4 | 2023 |
